초록 ▼

Methods for identifying a biological particle in a sample medium include generating an Electrophoretic Quasi-elastic Light Scattering (EQELS) spectrum for the biological particle in the sample medium. The EQELS spectrum is compared to a reference database comprising a plurality of spectra, and each

Methods for identifying a biological particle in a sample medium include generating an Electrophoretic Quasi-elastic Light Scattering (EQELS) spectrum for the biological particle in the sample medium. The EQELS spectrum is compared to a reference database comprising a plurality of spectra, and each of the plurality of spectra correspond to an EQELS spectrum for one of a plurality of known biological particles. The biological particle in the sample medium is identified from the comparison.

대표청구항 ▼

That which is claimed is: 1. A system for identifying an unknown biological particle in a sample medium, said system comprising: an Electrophoretic Quasi-elastic Light Scattering (EQELS) spectrometer comprising an EQELS controller configured to generate a EQELS spectrum for the biological particle

That which is claimed is: 1. A system for identifying an unknown biological particle in a sample medium, said system comprising: an Electrophoretic Quasi-elastic Light Scattering (EQELS) spectrometer comprising an EQELS controller configured to generate a EQELS spectrum for the biological particle in the sample medium, wherein said biological particle comprises a biological cell; an EQELS analyzer in communication with said EQELS spectrometer; a reference database in communication with said EQELS analyzer, said reference database comprising a plurality of spectra, each of said plurality of spectra corresponding to an EQELS spectrum for one of a plurality of different types of known biological cells; wherein said EQELS analyzer is configured to compare said EQELS spectrum for the unknown biological particle in the sample medium from said EQELS spectrometer with said plurality of spectra from said reference database and to identify the unknown biological particle in the sample medium from the comparison. 2. The system of claim 1, wherein said biological cell is a microbe selected from the group consisting of viruses, bacteria, fungi, and protozoa. 3. The system of claim 1, wherein said EQELS spectrum comprises a first EQELS spectrum, and said EQELS spectrometer further comprises: a sample chamber configured to receive the sample medium; a sample modification system in communication with said sample chamber and configured to modify the sample; and wherein said EQELS spectrometer controller is configured to modify the sample with said sample modification system after detecting said first EQELS spectrum and to detect a second EQELS spectrum after modifying the sample; wherein said EQELS analyzer is configured to compare said first EQELS spectrum to said second EQELS spectrum to characterize the biological particle in the sample medium from the comparison. 4. The system of claim 3, wherein said sample modification system is configured to add an antibody to said sample medium, wherein the antibody is a specific binder to a predetermined biological particle, and wherein said EQELS analyzer is configured to determine if the biological particle in the sample medium is the predetermined biological particle from the comparison of said first EQELS spectrum to said second EQELS spectrum. 5. The system of claim 3, wherein said modification system is configured to modify the sample medium by adding a therapeutic agent to said sample medium, and wherein said EQELS analyzer is configured to assess an effectiveness of said therapeutic agent based on said comparison of said first EQELS spectrum and said second EQELS spectrum. 6. The system of claim 5, wherein said EQELS analyzer is configured to determine if the therapeutic agent binds to a surface of the biological particle. 7. The system of claim 5, wherein the biological particle is a microbe and said EQELS analyzer is configured to determine a change in swim rate of the biological particle. 8. The system of claim 5, wherein said EQELS analyzer is configured to determine a binding constant for the therapeutic agent. 9. The system of claim 5, wherein the biological particle is a microbe and said EQELS analyzer is configured to determine a swim rate for the microbe and to identify the microbe based on the swim rate, wherein said database includes swim rates for the plurality of known microbes. 10. The system of claim 1, wherein said EQELS spectrometer further comprises: an electric field generator for exposing the biological particle in the sample medium to an electric field; a light source configured to impinge an excitation light on the biological particle in the sample medium to produce scattered light; a detector configured to detect the scattered light; wherein said EQELS analyzer is configured to detect a Doppler shift in the scattered light compared to the excitation light. 11. The system of claim 1, wherein the biological particle is a microbe and wherein said EQELS analyzer is configured to identify the microbe by determining a ratio of a swim rate of the microbe to the electrophoretic mobility of the microbe. 12. The system of claim 1, further comprising a filtration device configured to collect the biological particle from a fluid. 13. The system of claim 12, wherein said filtration device further comprises: a filter configured to filter a gas and/or liquid and to trap the biological particle therein; and a flushing inlet configured to flush the biological particle with a fluid to provide the sample medium. 14. The system of claim 13, wherein said filtration device is configured to collect a sample automatically. 15. The system of claim 1, wherein the cell is a virus. 16. The system of claim 1, wherein the cell is a bacteria. 17. The system of claim 1, wherein the cell is a fungi. 18. The system of claim 1, wherein the cell is a protozoa. 19. The system of claim 1, wherein the cell is a blood cell. 20. The system of claim 1, wherein the cell is a white blood cell. 21. The system of claim 1, wherein the cell is a red blood cell. 22. The system of claim 1, wherein the cell is a platelet. 23. The system of claim 1, wherein the cell is a cultured cell. 24. The system of claim 1, wherein the cell is a suspended endothelial cell. 25. The system of claim 1, wherein the cell is a nucleated cell. 26. The system of claim 1, wherein the cell is a non-nucleated cell. 27. The system of claim 1, wherein the cell is a human cell. 28. The system of claim 1, wherein the cell is a cloned cell. 29. The system of claim 1, wherein the cell is a plant cell. 30. The system of claim 1, wherein the cell is an animal cell. 31. The system of claim 1, wherein the cell is a biopsied cell. 32. The system of claim 1, wherein the cell is fixed with a preservative.